** US government to fund up to $500 mln for studies on oral, nasal COVID vaccines **
VXRT
The U.S. Department of Health and Human Services (HHS) said on Thursday it will provide up to $500 million for mid-stage trials evaluating vaccines administered as a nasal spray or pill to protect against symptomatic COVID-19.
The reason I'm so bullish on this one is because of what it represents, the storage and distribution of vaccine without the need for refrigeration. Throughout the world there are folks who do have access to some of the most basic vaccines because of this simple problem of logistics.